Evidence map›Paper›PMID 32428303›Full record

ReviewJournal of the European Academy of Dermatology and Venereology : JEADV2020

COVID-19 and dermatology: a comprehensive guide for dermatologists.

D H Fahmy, H S El-Amawy, M A El-Samongy, A A Fouda, S H Soliman, A El-Kady, F Farnetani, A Conti, A Zoeir, A Eissa and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the European Academy of Dermatology and Venereology : JEADV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Skin manifestations of COVID-19 in children: Part 3.Clinical and experimental dermatology · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

D H FahmyDermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
H S El-AmawyDermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
M A El-SamongyDermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
A A FoudaDermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
S H SolimanDermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
A El-KadyDermatology Department, El-Menshawy Hospital, Ministry of Health & Population, Tanta, Egypt.
F FarnetaniDermatology Department, University of Modena & Reggio Emilia, Modena, Italy.ORCID https://orcid.org/0000-0001-7088-9077
A ContiDermatology Department, Azienda Ospedaliero Universitaria of Modena, Modena, Italy.
A ZoeirUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
A EissaUrology Department, University of Modena & Reggio Emilia, Modena, Italy.ORCID https://orcid.org/0000-0001-6817-6887
R EissaMicrobiology & Virology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
S PuliattiUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
M C SighinolfiUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
B RoccoUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
G PellacaniDermatology Department, University of Modena & Reggio Emilia, Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DermatologistsPractice Guidelines as TopicBetacoronavirusCoronavirus InfectionsCOVID-19Dermatologic AgentsGenes, ViralHumansInfection ControlOccupational DiseasesPandemicsPneumonia, ViralSARS-CoV-2Skin DiseasesDermatologic Agents

Identifiers

PMID32428303
PMCPMC7276795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.